Buy Crypto Markets Spot FuturesBTC Earn Event Center Rewards Hub

Champions Oncology, Inc. (CSBR)

NASDAQ

$4.96

$-0.28

(-5.34%)

Market Closed

Champions Oncology, Inc. (CSBR) Live Price Chart

Last updated: ⁦2026-08-21 23:49:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Key Market Data

Market Cap	$68.63M
Open	$5.24
High	$17.90
Low	$1.11
Previous Close	$5.18
Price Change	$-0.28
Percentage Change	-5.34%
Volume	8K

Champions Oncology, Inc. (CSBR) Stock Price Today

Champions Oncology, Inc. (CSBR) is currently trading at $4.96 as of 2026-08-21 23:31:00, reflecting a -5.34% move ($-0.28) from the previous close.

In the short term, the stock has returned -17.33% over the past four weeks. Over the last 12 months, Champions Oncology, Inc. has recorded a -33.06% price change, indicating a Weak performance relative to the broader market.

Champions Oncology, Inc. (CSBR) 7-Day Stock Price Changes

Over the past seven days, Champions Oncology, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $5.01 to the latest recorded price of $4.96, reflecting an intraday change of -5.34%. Daily movements highlight shifts in trading volume (8,126), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, CSBR has delivered a -17.33% return over the past month and a -33.06% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy Champions Oncology, Inc. (CSBR)

You can buy and trade CSBR on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for CSBR and Execute Your Trade

Open the trading page, enter CSBR in the search bar, select the amount of CSBR you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Champions Oncology, Inc. (CSBR)?

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

Champions Oncology, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	214
Sector	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Website	https://www.championsoncology.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Champions Oncology, Inc.?

The latest trading price for Champions Oncology, Inc. (Common Stock) is $ 4.96, compared with a previous closing price of $ 5.18. That means the stock has moved -5.34% so far today. Intraday price updates and recent trading activity for CSBR can be tracked on the live chart and quote section on this page.

2.Is Champions Oncology, Inc. stock going up or down?

Looking at recent performances, CSBR has returned -17.33% over the past month, -15.21% over the last six months and -33.06% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for Champions Oncology, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does CSBR currently sit relative to its 52-week high and low?

In the most recent 52-week period, Champions Oncology, Inc. has traded between a low of $ 4.83 and a high of $ 8.74. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether CSBR is currently nearer the top or the bottom of its one-year trading band.

4.How is Champions Oncology, Inc. classified by sector and industry?

Champions Oncology, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. In practice, this means Champions Oncology, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing CSBR’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector could influence Champions Oncology, Inc.’s performance.

5.Where is Champions Oncology, Inc. listed and how large is it by market value?

Champions Oncology, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 68.63M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Champions Oncology, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does CSBR's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.08 summarises how much profit Champions Oncology, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Champions Oncology, Inc.'s financial performance over time?

To follow Champions Oncology, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how CSBR is performing and how the market is responding.

8.When is Champions Oncology, Inc. expected to report earnings?

Champions Oncology, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for CSBR, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Champions Oncology, Inc.'s earnings reports?

Champions Oncology, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether CSBR is meeting, beating or missing expectations.

10.How can I stay informed about Champions Oncology, Inc.'s results and guidance?

You can stay up to date on Champions Oncology, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for CSBR on this page helps you see how new information is being reflected in the stock.

11.Does Champions Oncology, Inc. pay a regular cash dividend to its shareholders?

Champions Oncology, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor CSBR's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for CSBR?

Based on the latest earnings data, CSBR has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Champions Oncology, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Champions Oncology, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Champions Oncology, Inc.?

Champions Oncology, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is CSBR valued in terms of P/E ratio and EPS?

Champions Oncology, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.08. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Champions Oncology, Inc.'s earnings. Comparing CSBR's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Marvell Technology, Inc.

MRVL

Western Digital Corp.

WDC

CrowdStrike Holdings, Inc.

Top Gainers

Browse today's leading gainers in the US stock market

RF Acquisition Corp II

RFAI

StablecoinX Inc.

USDE

Werewolf Therapeutics, Inc.

HOWL

Sadot Group Inc.

SDOT

AIAI Holdings Corporation

AIAI

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

MEXC Aug 8: Share $500K

Refer friends early to earn 888% APR and $3,888

CSBR-to-USD Calculator

Amount

CSBR

USD

1 CSBR = 4.96 USD